Company Cardiorad S.r.l. with Fiscal Code 35395051
recorded a turnover of 2024 of
22.924,
with a net profit of
15.681
and having an average number of employees of
- .
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Cardiorad S.r.l.
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
16.119
19.989
6.909
11.181
9.457
13.563
15.868
17.384
22.924
Total Income - EUR
-
16.144
20.394
19.952
12.218
9.554
13.563
15.874
19.041
22.924
Total Expenses - EUR
-
1.367
2.321
1.869
2.415
2.596
3.054
3.028
3.719
4.367
Gross Profit/Loss - EUR
-
14.777
18.073
18.083
9.803
6.958
10.509
12.847
15.322
18.556
Net Profit/Loss - EUR
-
14.293
17.462
17.876
9.553
6.675
10.217
12.370
13.246
15.681
Employees
-
0
0
0
0
0
0
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 32.6%, from 17.384 euro in the year 2023, to 22.924 euro in 2024.
The Net Profit increased by 2.509 euro, from 13.246 euro in 2023, to 15.681 in the last year.
Check the financial reports for the company - Cardiorad S.r.l.
Financial Rating - CARDIORAD S.R.L.
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Cardiorad S.r.l.
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Cardiorad S.r.l.
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Cardiorad S.r.l.
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
17.730 euro in 2024 which includes Inventories of
211 euro, Receivables of
3.120 euro and cash availability of
14.398 euro.
The company's Equity was valued at
15.753 euro, while total Liabilities amounted to
2.560 euro.
Equity decreased by -467 euro, from 16.311 euro in 2023, to 15.753 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Cardiorad S.r.l.